Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15423982 | 0.95 | ALDH1A1 (0.39) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL15423979 | 0.77 | CYP3A4 (0.43) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL12559554 | 0.69 | — | — | |
| SCHEMBL12559544 | 0.65 | — | — | |
| SCHEMBL15423981 | 0.63 | ALDH1A1 (0.52) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL12559550 | 0.62 | ALDH1A1 (0.43) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL15423980 | 0.62 | ALDH1A1 (0.38) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL7219856 | 0.62 | — | — | |
| SCHEMBL146892 | 0.61 | ALDH1A1 (0.58) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL29701329 | 0.60 | ALDH1A1 (0.70) | ALDH1A1TP53CYP3A4TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140018379-A1 | PYRIMIDINE DERIVATIVES | CONCERT PHARMACEUTICALS INC. (US) | 2014-01-16 | — | — | US | disclosed |
| EP-2536696-A1 | PYRIMIDINE DERIVATIVES | Concert Pharmaceuticals Inc. (US) | 2012-12-26 | — | — | EP | disclosed |
| WO-2011103457-A1 | PYRIMIDINE DERIVATIVES | CONCERT PHARMACEUTICALS INC. (US) | 2011-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140018379-A1 | PYRIMIDINE DERIVATIVES | DPYD, TYMS, TYMP | ALDH1A1 518/4885TP53 496/4885CYP3A4 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.